Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis
- PMID: 25856213
- PMCID: PMC4454799
- DOI: 10.1210/jc.2015-1438
Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis
Abstract
Objective: The objective was to determine the risk of stroke associated with subclinical hypothyroidism.
Data sources and study selection: Published prospective cohort studies were identified through a systematic search through November 2013 without restrictions in several databases. Unpublished studies were identified through the Thyroid Studies Collaboration. We collected individual participant data on thyroid function and stroke outcome. Euthyroidism was defined as TSH levels of 0.45-4.49 mIU/L, and subclinical hypothyroidism was defined as TSH levels of 4.5-19.9 mIU/L with normal T4 levels.
Data extraction and synthesis: We collected individual participant data on 47 573 adults (3451 subclinical hypothyroidism) from 17 cohorts and followed up from 1972-2014 (489 192 person-years). Age- and sex-adjusted pooled hazard ratios (HRs) for participants with subclinical hypothyroidism compared to euthyroidism were 1.05 (95% confidence interval [CI], 0.91-1.21) for stroke events (combined fatal and nonfatal stroke) and 1.07 (95% CI, 0.80-1.42) for fatal stroke. Stratified by age, the HR for stroke events was 3.32 (95% CI, 1.25-8.80) for individuals aged 18-49 years. There was an increased risk of fatal stroke in the age groups 18-49 and 50-64 years, with a HR of 4.22 (95% CI, 1.08-16.55) and 2.86 (95% CI, 1.31-6.26), respectively (p trend 0.04). We found no increased risk for those 65-79 years old (HR, 1.00; 95% CI, 0.86-1.18) or ≥ 80 years old (HR, 1.31; 95% CI, 0.79-2.18). There was a pattern of increased risk of fatal stroke with higher TSH concentrations.
Conclusions: Although no overall effect of subclinical hypothyroidism on stroke could be demonstrated, an increased risk in subjects younger than 65 years and those with higher TSH concentrations was observed.
Figures
References
-
- Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–238. - PubMed
-
- Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab. 2005;90:581–585; discussion 586–587. - PubMed
-
- Helfand M, U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:128–141. - PubMed
-
- Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab. 1999;84:561–566. - PubMed
-
- Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002). Thyroid. 2007;17:1211–1223. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01-AG028050/AG/NIA NIH HHS/United States
- N01-AG-6-2101/AG/NIA NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- R01-NR012459/NR/NINR NIH HHS/United States
- K24 AG042765/AG/NIA NIH HHS/United States
- U01 AG042145/AG/NIA NIH HHS/United States
- R01 NR012459/NR/NINR NIH HHS/United States
- R01AG032317/AG/NIA NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- N01-AG-6-2106/AG/NIA NIH HHS/United States
- R01 AG032317/AG/NIA NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- N01 HC085080/HL/NHLBI NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- N01 HC085082/HL/NHLBI NIH HHS/United States
- K24 AR051895/AR/NIAMS NIH HHS/United States
- UL1 TR000128/TR/NCATS NIH HHS/United States
- K24AG042765/AG/NIA NIH HHS/United States
- N01-AG-6-2103/AG/NIA NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC085083/HL/NHLBI NIH HHS/United States
- G1000143/MRC_/Medical Research Council/United Kingdom
- U01 AG042124/AG/NIA NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- U01 AG042168/AG/NIA NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- AG023629,19/AG/NIA NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- R01 HL080295/HL/NHLBI NIH HHS/United States
- R01 AG028050/AG/NIA NIH HHS/United States
- HL080295/HL/NHLBI NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- R56 AG023629/AG/NIA NIH HHS/United States
- U01 AG042143/AG/NIA NIH HHS/United States
- N01 HC085081/HL/NHLBI NIH HHS/United States
- U01 AG042139/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
